Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Propel Media is a diversified online advertising company that operates the Propel Media Platform and DeepIntent; DeepIntent is one of the top three demand-side platforms for programmatic advertising of prescription drugs and other healthcare products to healthcare professionals, which led to FTC action to block IQVIA’s attempted acquisition on antitrust grounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Propel Media.